Utah Medical Products, Inc.
UTMD
$56.35
$0.681.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.42% | 2.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.42% | 2.50% | |||
| Cost of Revenue | -3.44% | 4.46% | |||
| Gross Profit | 0.16% | 1.03% | |||
| SG&A Expenses | 22.83% | 3.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.17% | 3.75% | |||
| Operating Income | -13.69% | 0.26% | |||
| Income Before Tax | -13.74% | -0.57% | |||
| Income Tax Expenses | -13.96% | -3.55% | |||
| Earnings from Continuing Operations | -13.68% | 0.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.68% | 0.23% | |||
| EBIT | -13.69% | 0.26% | |||
| EBITDA | -11.04% | 1.05% | |||
| EPS Basic | -12.64% | 2.21% | |||
| Normalized Basic EPS | -9.07% | 0.60% | |||
| EPS Diluted | -12.67% | 2.21% | |||
| Normalized Diluted EPS | -9.07% | 0.61% | |||
| Average Basic Shares Outstanding | -1.19% | -1.93% | |||
| Average Diluted Shares Outstanding | -1.19% | -1.94% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.14% | -0.02% | |||